The impact of COVID-19 on select considerations in patients of reproductive age: Brief talking points for pharmacists
- 1 May 2023
- journal article
- editorial
- Published by Elsevier BV in Journal of the American Pharmacists Association
- Vol. 63 (3), 720-724
- https://doi.org/10.1016/j.japh.2023.01.003
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- The Impact of the COVID-19 Pandemic on Women’s Reproductive HealthFrontiers in Endocrinology, 2021
- The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysisCMAJ : Canadian Medical Association Journal, 2021
- COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countriesEuropean Journal of Epidemiology, 2021
- Disease severity, pregnancy outcomes, and maternal deaths among pregnant patients with severe acute respiratory syndrome coronavirus 2 infection in Washington StateAmerican Journal of Obstetrics and Gynecology, 2021
- Community Pharmacists Roles During the COVID-19 PandemicJournal of Pharmacy Practice, 2020
- Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020Morbidity and Mortality Weekly Report (MMWR), 2020
- Are clinical outcomes worse for pregnant women at ≥20 weeks’ gestation infected with coronavirus disease 2019? A multicenter case-control study with propensity score matchingAmerican Journal of Obstetrics and Gynecology, 2020
- On the frontline against COVID-19: Community pharmacists’ contribution during a public health crisisResearch in Social and Administrative Pharmacy, 2020
- Risk of venous thromboembolism in users of contraception and menopausal hormone therapy during the COVID-19 pandemicRevista da Associação Médica Brasileira, 2020
- Randomized Clinical Trials and Observational Studies Are More Often Alike Than UnlikeJAMA Internal Medicine, 2014